Coty Inc. — Form 10-K Summary
Reporting period: Fiscal year ended June 30, 2015. This is an annual filing, not a standalone fiscal 2014 fourth-quarter report; it includes fourth-quarter results for the three months ended June 30, 2015. Amounts are in U.S. dollars unless stated otherwise.
Business context
Coty is a global beauty company operating in Fragrances, Color Cosmetics, and Skin & Body Care, selling prestige and mass-market products in more than 130 countries. Its ten power brands generated 72% of fiscal 2015 revenue. The company ranked second globally in fragrances and fourth in color cosmetics. Net revenue mix was approximately 50% fragrances, 33% color cosmetics, and 17% skin and body care.
Financial performance and liquidity
| Metric | FY2015 | FY2014 |
|---|---|---|
| Net revenue | $4,395.2 million | $4,551.6 million |
| Gross profit / gross margin | $2,638.2 million / 60.0% | $2,685.9 million / 59.0% |
| Operating income / margin | $395.1 million / 9.0% | $25.7 million / 0.6% |
| Adjusted operating income / margin (non-GAAP) | $528.9 million / 12.0% | $500.6 million / 11.0% |
| Net income (loss) attributable to Coty Inc. | $232.5 million | $(97.4) million |
| Diluted EPS attributable to Coty Inc. | $0.64 | $(0.26) |
| Adjusted net income attributable to Coty Inc. (non-GAAP) | $359.5 million | $316.2 million |
| Operating cash flow | $526.3 million | $536.5 million |
| Cash and cash equivalents at year-end | $341.3 million | $1,238.0 million |
| Total debt at year-end | $2,634.7 million | $3,293.5 million |
Revenue declined 3% year over year, principally due to a 5% unfavorable foreign-exchange translation effect; unit volume and price/mix each contributed approximately 1% positively. Excluding currency, the TJoy/China Optimization impacts, and Bourjois, revenue was described as broadly consistent with the prior year. Cost of sales fell to 40.0% of revenue from 41.0%, improving gross margin by about 100 basis points. Adjusted operating income rose 6%; this non-GAAP measure excludes specified items and should be considered alongside GAAP results.
Segment revenue and operating income were: Fragrances, $2,178.3 million and $352.7 million; Color Cosmetics, $1,445.0 million and $158.5 million; Skin & Body Care, $771.9 million and $33.1 million. Fragrances revenue fell 6%, Color Cosmetics rose 6%, and Skin & Body Care fell 10%. The largest segment operating-income comparison was Skin & Body Care, which moved from a $337.3 million loss in FY2014, when it recorded $316.9 million of impairment charges, to $33.1 million of income in FY2015.
For the June 2015 quarter, revenue was $1,019.5 million versus $1,041.5 million a year earlier. Coty reported an operating loss of $23.4 million, including $32.2 million of acquisition-related costs, and net income attributable to Coty Inc. of $21.0 million.
Cash from operations was $526.3 million; capital expenditures were $170.9 million. Cash fell by $896.7 million during the year, mainly reflecting debt repayments and other financing outflows, as well as a $113.6 million adverse foreign-exchange effect on cash. Coty had $1,113.5 million available for borrowing under its revolving facility at June 30, 2015 and reported compliance with its financial covenants. Most long-term debt matures in fiscal 2018; scheduled long-term debt obligations for that year were $2,430.0 million.
Material changes and unusual items
- FY2014 included $316.9 million of asset impairment charges, including $256.4 million of goodwill and $60.5 million of other assets associated with the Skin & Body Care reporting unit and TJoy operations in China. No asset impairment charges were recorded in FY2015.
- Coty acquired the Bourjois cosmetics business on April 1, 2015, for consideration valued at $376.8 million, paid in Coty shares. Bourjois contributed $46.1 million of revenue and a $16.1 million net loss from acquisition through year-end; its purchase-price allocation remained preliminary.
- Coty prepaid $500.0 million of Senior Notes in September 2014 and recorded an $88.8 million loss on early extinguishment of debt, including a make-whole amount and deferred financing-fee write-off.
- The FY2015 income-tax benefit was $26.1 million, producing an effective tax rate of negative 11.2%. The filing cites a $62.0 million benefit from tax-audit settlements and statute expirations. The prior-year effective rate was also affected by impairment-related tax expense and valuation allowances.
- Foreign-currency translation reduced FY2015 comprehensive results; the foreign-currency translation adjustment was a loss of $228.4 million.
Outlook, management commentary, and risks
Management’s long-term aims include growing revenue in line with or ahead of relevant markets, steadily expanding margins, and generating strong cash flow. Coty targeted annual savings of $270 million from its global efficiency plan by the end of fiscal 2017; separately, the Organizational Redesign was expected to generate $160 million of annual savings by that date. Coty reported $45 million of annual savings from China Optimization as of June 30, 2015. These are targets, not guarantees. The filing does not provide a specific near-term revenue or earnings forecast.
On July 8, 2015, after fiscal year-end, Coty announced a proposed tax-free Reverse Morris Trust transaction to combine with P&G’s fine fragrance, color cosmetics, and hair color businesses. The transaction was expected to close in the second half of calendar 2016, subject to approvals and other conditions. P&G shareholders were expected to own 52% of the combined company, and Coty’s existing shareholders 48%. Coty disclosed that it would assume P&G Beauty Business debt contractually set at $2.9 billion, subject to adjustment, and anticipated refinancing its existing debt. Integration, financing, regulatory, licensor-consent, and realization-of-synergies risks are significant.
- Competition, promotional discounting, changing consumer preferences, product life-cycle declines, and retailer inventory and shelf-space decisions could pressure sales and margins. Management noted difficult mass-market conditions, particularly in the U.S. and Western Europe.
- Currency movements materially affected reported revenue and cash; Coty also faces international operating, regulatory, sanctions, and tax risks. Most cash was held outside the U.S. under a permanent-reinvestment policy.
- Licensed brands accounted for 57% of FY2015 revenue; loss or unfavorable renewal of important licenses could materially affect the business.
- The U.S. Commerce Department’s antiboycott compliance office continued reviewing potential invoice-certification violations involving a UAE subsidiary. Coty said a material loss was reasonably possible, had not established a reserve, and could not estimate any penalty. Separate export-control and OFAC matters resulted in an OEE warning letter and an OFAC cautionary letter, respectively, with no financial penalties imposed.
- A securities class action relating to Coty’s IPO remained pending, with the company’s motion to dismiss awaiting decision. Management said it intended to defend the case.
- Goodwill and other intangible assets are significant. FY2015 annual testing found no impairment, but the philosophy trademark had only about an 11% estimated fair-value cushion over carrying value.
Important facts for investors to verify
- Reconcile GAAP earnings with adjusted results, especially the effects of the $88.8 million debt-extinguishment loss, restructuring and acquisition costs, and the unusual tax benefit.
- Track revenue trends excluding currency, Bourjois, and China Optimization, with attention to fragrances and Skin & Body Care, and whether new launches offset declines in mature products.
- Assess execution and cash costs for the savings programs and the integration of Bourjois; compare realized savings with the stated targets.
- Monitor the P&G transaction’s closing conditions, final debt assumed, refinancing terms, dilution, integration costs, and expected synergies.
- Review debt maturities and covenant headroom, liquidity after the year-end cash reduction, and the substantial fiscal 2018 repayment concentration.
- Follow the OAC antiboycott review, any reserve or penalty developments, and the IPO securities litigation.